Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Radioactive iodine therapy for differentiated thyroid cancer commonly causes throat/mouth symptoms, psychological distress, and fatigue, with rare serious side effects like bone…
Yes, a phase IIa trial found becotatug vedotin produced a 20.9% objective response rate in recurrent head and neck squamous cell carcinoma after prior therapy.
Yes, research suggests periodontal disease is linked to a higher risk of pancreatic cancer in older adults, possibly due to chronic inflammation and oral bacteria.
Yes, nivolumab plus ipilimumab provides a 5-year survival benefit for pleural mesothelioma, with 14% vs 6% survival rates compared to chemotherapy.
Serum biomarkers show promise but are not yet accurate enough alone for early oral cancer detection; combining multiple biomarkers improves accuracy.
Yes, adding HITHOC to surgery modestly improves survival for pleural mesothelioma patients without raising early postoperative risk, based on recent meta-analyses.
Yes, immune microenvironment characterization helps identify immune subtypes and biomarkers to guide precision immunotherapy in thyroid cancer, especially for aggressive forms.
Yes, the Systemic Immune-Inflammation Index (SII) can help predict lymph node metastasis in thyroid cancer, with studies showing moderate diagnostic accuracy.
Yes, the Systemic Immune-Inflammation Index (SII) shows moderate diagnostic accuracy for thyroid cancer, with pooled sensitivity of 76.8% and specificity of 71.2% based on a…
Yes, the gut microbiome likely influences thyroid cancer development through immune regulation, hormone metabolism, and metabolite production, though direct evidence in humans is…
Yes, encorafenib plus binimetinib is effective for BRAF V600E-mutated thyroid cancer, with a 54.5% objective response rate in a phase 2 trial, including responses in both…
Yes, chemoimmunotherapy improves survival in patients with liver metastases, with benefits similar to those without liver metastases, according to a large meta-analysis.
Yes, robotic surgery appears safe for treating colorectal cancer and liver metastases together in selected patients, with low conversion rates and no reported deaths in early…
Yes, thermal ablation is a safe and effective treatment for small colorectal liver metastases, with low complication rates and survival outcomes comparable to surgery.
Immune checkpoint inhibitors (ICIs) show reduced effectiveness in patients with liver metastases, but combining them with local treatments or certain targeted therapies may…
Combined pelvic and para-aortic lymphadenectomy may improve survival in intermediate/high-risk endometrial cancer, but evidence is mixed and not definitive for all stages.
Current research focuses on PD-1/PD-L1 inhibitors, especially for MSI-H tumors, combination therapies, and understanding molecular subtypes to improve immunotherapy response in…
HPV evades innate immune detection by suppressing PRR signaling and NLRP3 inflammasome, enabling persistent infection and cervical cancer progression.
EGCG shows promise against esophageal cancer in lab and animal studies, and a human trial found it reduced radiation-induced esophagitis, but more clinical research is needed.
Yes, conversion surgery after induction therapy significantly improves survival for cT4 esophageal cancer, with 5-year survival of 26.5% vs 11.6% for definitive therapy alone.
While older age and other health issues are often associated with higher risks in open surgeries, research suggests they may not increase the risk of severe complications for…
Yes, relacorilant plus nab-paclitaxel improves survival in platinum-resistant ovarian cancer, based on phase 2 and phase 3 trial results.
Yes, PARP inhibitors significantly improve progression-free survival for patients with BRCA-mutated ovarian cancer, with some studies also showing overall survival benefits.
Yes, [68Ga]Ga-FAPI PET imaging is highly accurate for diagnosing ovarian cancer, especially for detecting peritoneal and lymph node metastases, and may outperform standard FDG…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.